Penelope Jane Hallett, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 26 | 2023 | 2775 | 2.420 |
Why?
|
Glucosylceramidase | 11 | 2023 | 125 | 1.890 |
Why?
|
alpha-Synuclein | 12 | 2023 | 722 | 1.830 |
Why?
|
Substantia Nigra | 7 | 2020 | 353 | 1.100 |
Why?
|
Lysosomes | 9 | 2023 | 893 | 1.080 |
Why?
|
Mesencephalon | 4 | 2017 | 329 | 1.080 |
Why?
|
Lewy Body Disease | 1 | 2023 | 229 | 0.780 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2020 | 53 | 0.760 |
Why?
|
Gangliosides | 1 | 2020 | 137 | 0.700 |
Why?
|
Corpus Striatum | 8 | 2011 | 1221 | 0.680 |
Why?
|
Secretogranin II | 1 | 2018 | 11 | 0.680 |
Why?
|
Nerve Degeneration | 5 | 2019 | 748 | 0.670 |
Why?
|
Glycosphingolipids | 2 | 2021 | 79 | 0.660 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 5 | 2009 | 896 | 0.600 |
Why?
|
Dyskinesias | 2 | 2007 | 78 | 0.520 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2023 | 1736 | 0.500 |
Why?
|
Axonal Transport | 2 | 2015 | 177 | 0.490 |
Why?
|
Toll-Like Receptor 3 | 3 | 2023 | 91 | 0.440 |
Why?
|
Fetal Tissue Transplantation | 3 | 2009 | 139 | 0.430 |
Why?
|
tau Proteins | 2 | 2019 | 1868 | 0.420 |
Why?
|
Receptors, Dopamine D1 | 4 | 2009 | 291 | 0.400 |
Why?
|
Stem Cell Transplantation | 3 | 2015 | 1620 | 0.390 |
Why?
|
Lipids | 2 | 2020 | 3307 | 0.380 |
Why?
|
Neurons | 11 | 2019 | 9340 | 0.370 |
Why?
|
Dopamine | 7 | 2018 | 1591 | 0.370 |
Why?
|
Brain | 9 | 2023 | 26388 | 0.360 |
Why?
|
Oxidative Stress | 2 | 2018 | 3084 | 0.350 |
Why?
|
Huntington Disease | 2 | 2014 | 1124 | 0.350 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2012 | 257 | 0.340 |
Why?
|
Synapses | 3 | 2014 | 1728 | 0.330 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2012 | 0.330 |
Why?
|
Dyskinesia, Drug-Induced | 4 | 2010 | 163 | 0.320 |
Why?
|
Membrane Glycoproteins | 2 | 2020 | 3771 | 0.320 |
Why?
|
Parkinsonian Disorders | 5 | 2013 | 275 | 0.320 |
Why?
|
Cell Fractionation | 1 | 2008 | 252 | 0.300 |
Why?
|
Protein Transport | 4 | 2021 | 1988 | 0.290 |
Why?
|
Receptors, Opioid, delta | 1 | 2007 | 47 | 0.290 |
Why?
|
Behavior, Animal | 2 | 2014 | 1881 | 0.280 |
Why?
|
Levodopa | 5 | 2010 | 219 | 0.280 |
Why?
|
Aging | 5 | 2021 | 8664 | 0.270 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 814 | 0.270 |
Why?
|
Urinary Bladder | 1 | 2012 | 1173 | 0.260 |
Why?
|
MPTP Poisoning | 1 | 2005 | 35 | 0.260 |
Why?
|
Animals | 35 | 2023 | 168768 | 0.250 |
Why?
|
Mice, Inbred DBA | 2 | 2018 | 642 | 0.240 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 473 | 0.230 |
Why?
|
RNA, Double-Stranded | 2 | 2023 | 290 | 0.230 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2014 | 422 | 0.230 |
Why?
|
Glycolipids | 2 | 2023 | 204 | 0.230 |
Why?
|
Neurotransmitter Agents | 2 | 2018 | 647 | 0.210 |
Why?
|
Gaucher Disease | 1 | 2023 | 112 | 0.210 |
Why?
|
Pluripotent Stem Cells | 3 | 2017 | 795 | 0.210 |
Why?
|
Inflammation | 2 | 2019 | 10637 | 0.210 |
Why?
|
Tyrosine | 1 | 2006 | 1462 | 0.200 |
Why?
|
Complement C3 | 1 | 2023 | 461 | 0.200 |
Why?
|
Rats | 13 | 2020 | 24252 | 0.200 |
Why?
|
Rats, Sprague-Dawley | 9 | 2020 | 8300 | 0.200 |
Why?
|
Lysosomal Storage Diseases | 1 | 2021 | 79 | 0.190 |
Why?
|
Sandhoff Disease | 1 | 2020 | 13 | 0.190 |
Why?
|
Neostriatum | 2 | 2014 | 250 | 0.190 |
Why?
|
Receptors, Scavenger | 1 | 2021 | 121 | 0.190 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18034 | 0.180 |
Why?
|
Fibroblasts | 3 | 2021 | 4162 | 0.170 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 21833 | 0.170 |
Why?
|
Macaca fascicularis | 4 | 2015 | 915 | 0.170 |
Why?
|
Mice | 15 | 2023 | 81201 | 0.170 |
Why?
|
Glucosylceramides | 1 | 2018 | 28 | 0.160 |
Why?
|
Brain Tissue Transplantation | 2 | 2008 | 81 | 0.160 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 52 | 0.160 |
Why?
|
Receptors, Cell Surface | 1 | 2008 | 2865 | 0.160 |
Why?
|
Parkinson Disease, Secondary | 2 | 2015 | 126 | 0.160 |
Why?
|
Polyubiquitin | 1 | 2018 | 70 | 0.150 |
Why?
|
Syndrome | 1 | 2023 | 3252 | 0.150 |
Why?
|
Neurites | 1 | 2018 | 388 | 0.140 |
Why?
|
Mitochondrial Diseases | 1 | 2020 | 320 | 0.140 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 4 | 2010 | 96 | 0.140 |
Why?
|
Inclusion Bodies | 2 | 2014 | 279 | 0.140 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9735 | 0.130 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 12073 | 0.130 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2015 | 41 | 0.130 |
Why?
|
Complement C1q | 1 | 2015 | 92 | 0.130 |
Why?
|
Poly I-C | 2 | 2015 | 115 | 0.130 |
Why?
|
Inositol | 1 | 2015 | 218 | 0.120 |
Why?
|
Synapsins | 1 | 2014 | 43 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2018 | 721 | 0.120 |
Why?
|
Antiparkinson Agents | 3 | 2010 | 184 | 0.120 |
Why?
|
Microglia | 3 | 2020 | 1267 | 0.120 |
Why?
|
Receptor, trkB | 1 | 2014 | 125 | 0.110 |
Why?
|
Macaca mulatta | 4 | 2010 | 2377 | 0.110 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 144 | 0.110 |
Why?
|
Gene Knock-In Techniques | 1 | 2014 | 418 | 0.110 |
Why?
|
Triglycerides | 1 | 2020 | 2453 | 0.110 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2014 | 322 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4222 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2014 | 2088 | 0.090 |
Why?
|
Transgenes | 1 | 2014 | 1009 | 0.090 |
Why?
|
Radioligand Assay | 2 | 2009 | 374 | 0.090 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2009 | 29 | 0.090 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2014 | 604 | 0.090 |
Why?
|
Adenoviridae | 1 | 2014 | 1101 | 0.090 |
Why?
|
Humans | 32 | 2023 | 744366 | 0.090 |
Why?
|
Atrophy | 1 | 2014 | 1584 | 0.090 |
Why?
|
Mutation | 6 | 2023 | 29786 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2014 | 1730 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2014 | 1185 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1206 | 0.080 |
Why?
|
Male | 17 | 2021 | 350115 | 0.080 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2008 | 115 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7323 | 0.080 |
Why?
|
Signal Transduction | 3 | 2009 | 23404 | 0.080 |
Why?
|
Receptors, AMPA | 1 | 2010 | 332 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2015 | 1862 | 0.080 |
Why?
|
Female | 18 | 2021 | 380193 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2916 | 0.080 |
Why?
|
Presynaptic Terminals | 1 | 2009 | 302 | 0.080 |
Why?
|
Reserpine | 1 | 2007 | 66 | 0.070 |
Why?
|
Metabolome | 1 | 2014 | 895 | 0.070 |
Why?
|
Heterozygote | 1 | 2014 | 2804 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2021 | 21748 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2014 | 2327 | 0.070 |
Why?
|
Tritium | 1 | 2007 | 745 | 0.070 |
Why?
|
Neurodegenerative Diseases | 1 | 2015 | 1061 | 0.070 |
Why?
|
Alternative Splicing | 1 | 2011 | 1117 | 0.070 |
Why?
|
Receptors, LDL | 1 | 2008 | 476 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1295 | 0.070 |
Why?
|
Spinal Cord | 1 | 2014 | 1810 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2007 | 233 | 0.070 |
Why?
|
Prosencephalon | 1 | 2007 | 303 | 0.060 |
Why?
|
Naltrexone | 1 | 2007 | 307 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2008 | 982 | 0.060 |
Why?
|
Acid Ceramidase | 1 | 2023 | 19 | 0.060 |
Why?
|
Glutamic Acid | 1 | 2009 | 1169 | 0.060 |
Why?
|
Pyridines | 1 | 2015 | 2825 | 0.060 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1019 | 0.050 |
Why?
|
Oxidopamine | 2 | 2015 | 169 | 0.050 |
Why?
|
Injections, Intraventricular | 2 | 2014 | 231 | 0.050 |
Why?
|
Protein Subunits | 1 | 2006 | 959 | 0.050 |
Why?
|
Narcotic Antagonists | 1 | 2007 | 562 | 0.050 |
Why?
|
Gene Expression | 5 | 2015 | 7798 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2009 | 7882 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2018 | 19233 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 40559 | 0.040 |
Why?
|
Thapsigargin | 1 | 2018 | 104 | 0.040 |
Why?
|
Hydrolases | 1 | 2019 | 139 | 0.040 |
Why?
|
Transfection | 3 | 2014 | 5895 | 0.040 |
Why?
|
Synaptic Vesicles | 2 | 2010 | 191 | 0.040 |
Why?
|
Phosphorylation | 2 | 2008 | 8436 | 0.040 |
Why?
|
Locomotion | 2 | 2013 | 378 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1438 | 0.040 |
Why?
|
Histones | 1 | 2008 | 2598 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6366 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.040 |
Why?
|
Aged | 5 | 2021 | 163288 | 0.040 |
Why?
|
Dopamine Agents | 2 | 2008 | 189 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2014 | 13035 | 0.040 |
Why?
|
Chromatin | 1 | 2008 | 2933 | 0.040 |
Why?
|
Valinomycin | 1 | 2015 | 19 | 0.030 |
Why?
|
Benzodiazepinones | 1 | 2015 | 51 | 0.030 |
Why?
|
Mitochondria | 2 | 2019 | 3514 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 72296 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2015 | 297 | 0.030 |
Why?
|
Middle Aged | 5 | 2021 | 213390 | 0.030 |
Why?
|
Cyclic AMP | 2 | 2009 | 1472 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2110 | 0.030 |
Why?
|
Vimentin | 1 | 2014 | 262 | 0.030 |
Why?
|
Complement Activation | 1 | 2015 | 453 | 0.030 |
Why?
|
Cell Line | 3 | 2015 | 16000 | 0.030 |
Why?
|
Astrocytes | 1 | 2020 | 1273 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 1146 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2014 | 730 | 0.020 |
Why?
|
Dependovirus | 1 | 2015 | 706 | 0.020 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2009 | 64 | 0.020 |
Why?
|
Leupeptins | 1 | 2009 | 122 | 0.020 |
Why?
|
Lentivirus Infections | 1 | 2009 | 12 | 0.020 |
Why?
|
Eye | 1 | 2013 | 729 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2566 | 0.020 |
Why?
|
Ubiquitin | 1 | 2014 | 851 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2015 | 1178 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2014 | 1225 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2013 | 1549 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2428 | 0.020 |
Why?
|
Microdialysis | 1 | 2008 | 158 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.020 |
Why?
|
Ventral Tegmental Area | 1 | 2009 | 142 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2726 | 0.020 |
Why?
|
Enkephalins | 1 | 2008 | 154 | 0.020 |
Why?
|
Protein Kinases | 1 | 2015 | 1640 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2008 | 274 | 0.020 |
Why?
|
Autophagy | 1 | 2015 | 1297 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2008 | 375 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1879 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 2007 | 232 | 0.020 |
Why?
|
Dynamins | 1 | 2007 | 152 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2008 | 475 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2008 | 475 | 0.020 |
Why?
|
Drosophila | 1 | 2013 | 1491 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 906 | 0.020 |
Why?
|
Amphetamine | 1 | 2007 | 225 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2716 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 836 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3424 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 625 | 0.020 |
Why?
|
Protein Binding | 2 | 2008 | 9384 | 0.020 |
Why?
|
Acetylation | 1 | 2008 | 1084 | 0.020 |
Why?
|
Methylation | 1 | 2008 | 1106 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2013 | 11486 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11366 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 627 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.020 |
Why?
|
Cerebellum | 1 | 2011 | 1488 | 0.020 |
Why?
|
Protein Precursors | 1 | 2008 | 1154 | 0.020 |
Why?
|
Species Specificity | 1 | 2008 | 2478 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2308 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 2943 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2009 | 14561 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1701 | 0.010 |
Why?
|
Carcinoma | 1 | 2014 | 2375 | 0.010 |
Why?
|
Endocytosis | 1 | 2007 | 985 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1813 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1775 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2700 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5181 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2008 | 1226 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1988 | 0.010 |
Why?
|
Proteins | 1 | 2015 | 6100 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40075 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3749 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3848 | 0.010 |
Why?
|
Binding Sites | 1 | 2008 | 6111 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13814 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5709 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18111 | 0.010 |
Why?
|
Graft Survival | 1 | 2008 | 3737 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16690 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1711 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9647 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9445 | 0.010 |
Why?
|
Adult | 2 | 2019 | 214052 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6234 | 0.010 |
Why?
|
Mental Disorders | 1 | 2007 | 6598 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35425 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 63107 | 0.000 |
Why?
|